Feedback / Questions
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
"$AUPH for FY'23 the Company is reiterating net product revenue guidance of $120 to $140M from sales of LUPKYNIS"
(,@BioStocks)
Feb 28, 2023
https://twitter.com/BioStocks/status/1630524418857238528
Feb 28, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next